FindTrial
Sign In

Evaluating the Benefits of Adding Homeopathy to Standard Care for People with Chronic Throat Irritation

Individualised Homeopathic Adjuvant Treatment versus Standard Care Alone in Chronic Pharyngeal Paraesthesia: A Prospective Comparative Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110957
Enrollment
200
Registered
2026-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J392- Other diseases of pharynx

Interventions

Intervention1: Adjuvant Individualised Homeopathy with Standard of Care (SOC): Group 1 (Homeopathy arm): No protocol-driven intervention is applied. Routine ENT management (lifestyle modifications, vo

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 18-99 years. 2 Persistent globus sensation, throat irritation, or frequent throat clearing lasting more than 3 months. 3 ENT specialist evaluation, including flexible nasopharyngolaryngoscopy, with no red-flag findings or requirement for immediate surgical intervention. 4 Baseline Glasgow Edinburgh Throat Scale (GETS-10) score equal to or more than 10 or Reflux Symptom Index (RSI) equal to or more than 13. 5 Voluntary choice of homeopathic treatment with written informed consent for data recording.

Exclusion criteria

Exclusion criteria: 1 Identified organic pathology necessitating immediate specific intervention (e.g., neoplasm, severe reflux laryngitis). 2 Current homeopathic treatment for the presenting complaint within the past 4 weeks. 3 Any condition likely to impair reliable follow-up or data provision.

Design outcomes

Primary

MeasureTime frame
Primary Outcome Measure Comparison of change between the two groups in GETS-10 score from baseline to end of 3 month treatment period (validated, specific instrument for globus and related throat symptoms). Timepoint: At baseline and 3 months—

Secondary

MeasureTime frame
Secondary Outcome Measures Change in RSI score from baseline to 3 months (validated tool capturing reflux-associated laryngeal symptoms, relevant to overlapping pathophysiology) in both groups. Proportion of patients achieving equal or more than 50% reduction in GETS-10 score (clinically meaningful improvement) or complete resolution (GETS-10 equal or less than 3 and RSI less than 13) at 3 months. Descriptive observations of endoscopic changes (e.g., reduced mucus, erythema, or lymphoid hyperplasia) if repeat endoscopy is performed in routine care. Timepoint: At baseline and 3 months—

Countries

India

Contacts

Public ContactDr Ashish Kumar Dixit

AIIMS Bhopal

ashish.ayush@aiimsbhopal.edu.in9599834711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026